1 active not recruiting, 1 completed, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow Clopenthixol: new trials by email Literature Review of Clopenthixol trials Research Report on Clopenthixol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder | Phase 4 | Active not recruiting | Dr. Stavroula Rakitzi | 84 | 2025-06-04 | 2026-05-01 |
| Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features | Phase 4 | Completed | Technical University of Munich | 21 | 2015-02-01 | 2018-10-11 |
| A Study in the Treatment of Acute Mania olanzapine, haloperidol, zuclopentixol - Bipolar Disorder | Phase 4 | Terminated | Eli Lilly and Company | 11 | 2004-10-01 | 2008-10-07 |
Bipolar Disorder (1) · Psychotic Disorders (1) · Schizophrenia (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Schizophrenia, Treatment-Resistant (1)
Dr. Stavroula Rakitzi (1) · Eli Lilly and Company (1) · Technical University of Munich (1)
Germany (1) · Greece (1) · Sweden (1)
Dr. Polyxeni Georgila, M. D. (1) · Dr. Stavroula Rakitzi, PhD (1) · Markus Dold, MD (1) · Stefan Leucht, Professor (1)